This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 114/4/273    most recent CIRCULATIONAHA.105.548016v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bernstein, D. Search for Related Content PubMed PubMed Citation Articles by Bernstein, D. Pubmed/NCBI databases Medline Plus Health Information Heart Diseases Heart Transplantation Related Collections Congestive CV surgery: transplantation, ventricular assistance, cardiomyopathy Pediatric and congenital heart disease, including cardiovascular surgery

(Circulation. 2006;114:273-280.)
© 2006 American Heart Association, Inc.

Congenital Heart Disease

Outcome of Listing for Cardiac Transplantation for Failed Fontan

A Multi-Institutional Study

D. Bernstein, MD; D. Naftel, PhD; C. Chin, MD; L.J. Addonizio, MD; P. Gamberg, RN; E.D. Blume, MD; D. Hsu, MD; C.E. Canter, MD; J.K. Kirklin, MD; W.R. Morrow, MD; Pediatric Heart Transplant Study

From Stanford University (D.B., C.C., P.G.), Stanford, Calif; The University of Alabama (D.N., J.K.K.), Birmingham; Columbia University (L.J.A., D.H.), New York, NY; Children’s Hospital Boston and Harvard Medical School (E.D.B.), Boston, Mass; Washington University (C.E.C.), St. Louis, Mo; and The University of Arkansas (W.R.M.), Little Rock.

Correspondence to Dr Daniel Bernstein, Division of Pediatric Cardiology, Stanford University, 750 Welch Rd, Suite 305, Palo Alto, CA 94304. E-mail danb{at}stanford.edu

Received March 8, 2005; revision received March 14, 2006; accepted May 5, 2006.

Background— The Fontan procedure is a successful palliation for children with single-ventricle physiology; however, many will eventually require heart transplantation. The purpose of this study was to determine risk factors for death awaiting transplantation and to examine results after transplantation in Fontan patients.

Methods and Results— A retrospective, multi-institutional review was performed of 97 Fontan patients <18 years of age listed at 17 Pediatric Heart Transplant Study centers from 1993 to 2001. Mean age at listing was 9.7 years (0.5 to 17.9 years); 25% were <4 years old; 53% were United Network for Organ Sharing status 1; 18% required ventilator support. Pretransplantation survival was 78% at 6 months and 74% at 12 months and was similar to 243 children with other congenital heart disease (CHD) and 747 children without congenital heart disease (No-CHD), who were also awaiting transplantation. Patients who were younger, status 1, had shorter interval since Fontan, or were on a ventilator were more likely to die while waiting. At 6 months, the probability of receiving a transplant was similar for status 1 and 2 (65% versus 68%); however, the probability of death was higher for status 1 (22% versus 5%). Seventy patients underwent transplantation. Survival was 76% at 1 year, 70% at 3 years, and 68% at 5 years, slightly less than CHD and No-CHD patients. Causes of death included infection (30%), graft failure (17%), rejection (13%), sudden death (13%), and graft coronary artery disease (9%). Protein-losing enteropathy (present in 34 patients) resolved in all who survived >30 days after transplantation.

Conclusions— Heart transplantation is an effective therapy for pediatric patients with a failed Fontan. Although early posttransplantation survival is slightly lower than other patients with CHD, long-term results are encouraging, and protein-losing enteropathy can be expected to resolve.

---

 

CLINICAL PERSPECTIVE

This article has been cited by other articles:

				J. M. Lamour, K. R. Kanter, D. C. Naftel, M. R. Chrisant, W. R. Morrow, B. S. Clemson, J. K. Kirklin, and CTRD (Cardiac Transplant Registry Database) and th The Effect of Age, Diagnosis, and Previous Surgery in Children and Adults Undergoing Heart Transplantation for Congenital Heart Disease. J. Am. Coll. Cardiol., July 7, 2009; 54(2): 160 - 165. [Abstract] [Full Text] [PDF]

				C. Mavroudis, B. J. Deal, C. L. Backer, R. D. Stewart, W. H. Franklin, S. Tsao, K. M. Ward, and R. A. DeFreitas 111 Fontan Conversions with Arrhythmia Surgery: Surgical Lessons and Outcomes Ann. Thorac. Surg., November 1, 2007; 84(5): 1457 - 1466. [Abstract] [Full Text] [PDF]

				C. S.D. Almond, J. E. Mayer Jr, R. R. Thiagarajan, E. D. Blume, P. J. del Nido, and D. B. McElhinney Outcome After Fontan Failure and Takedown to an Intermediate Palliative Circulation Ann. Thorac. Surg., September 1, 2007; 84(3): 880 - 887. [Abstract] [Full Text] [PDF]

				T. P. Graham Jr The Year in Congenital Heart Disease J. Am. Coll. Cardiol., July 24, 2007; 50(4): 368 - 377. [Full Text] [PDF]

				C. E. Canter, R. E. Shaddy, D. Bernstein, D. T. Hsu, M. R.K. Chrisant, J. K. Kirklin, K. R. Kanter, R. S.D. Higgins, E. D. Blume, D. N. Rosenthal, et al. Indications for Heart Transplantation in Pediatric Heart Disease: A Scientific Statement From the American Heart Association Council on Cardiovascular Disease in the Young; the Councils on Clinical Cardiology, Cardiovascular Nursing, and Cardiovascular Surgery and Anesthesia; and the Quality of Care and Outcomes Research Interdisciplinary Working Group Circulation, February 6, 2007; 115(5): 658 - 676. [Abstract] [Full Text] [PDF]